Women on menopausal hormone therapy face a decreased risk of low bone mineral density compared with those not using it, according to a study presented at ENDO 2026, the Endocrine Society's annual ...

Sclerostin, a glycoprotein predominantly secreted by osteocytes, serves as a critical inhibitor of Wnt signalling and thus regulates bone formation and homeostasis. In metabolic bone disorders such as ...

Metabolic bone disease (MBD) of prematurity remains a clinically challenging complication of preterm birth, characterised by undermineralisation of the skeleton due to deficiencies of calcium and ...

Osteoporosis is a common skeletal disorder characterized by excessive bone loss, leading to increased fragility and an increased risk of fractures. Osteoclasts, the bone-resorbing cells, are widely ...

There is a complex pathological relationship between diabetes and osteoporosis, two of the most common chronic diseases worldwide.

Primary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by excessive secretion of parathyroid hormone ...

A guideline treats heart disease, kidney disease, diabetes and obesity as connected conditions under one umbrella: CKM ...

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone ...

The 2026 ACC/AHA guidelines outline staging, risk assessment, and interdisciplinary care for CKM syndrome management.

NEW YORK--(BUSINESS WIRE)--Hospital for Special Surgery (HSS), the world's leading academic medical center specialized in musculoskeletal health, today announced the appointment of Matthew T. Drake, ...

In the first-ever clinical guideline on CKM syndrome, the American Heart Association (AHA) and the American College of ...